Your session is about to expire
← Back to Search
BMS-986369 for Healthy Subjects
Study Summary
The purpose of the study is to assess mass balance, biotransformation, and excretion of BMS-986369 following study drug administration.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Has the FDA granted certification to BMS-986369?
"The safety of BMS-986369 was rated a 1 due to the fact that this is a Phase 1 trial, meaning there has only been minimal testing and research done on it thus far."
Is eligibility for this medical trial limited to those aged 40 and below?
"The eligibility requirements for this medical trial establish 18 years as the lower limit and 55 years old as the upper boundary."
Are there any vacancies in this test for participants?
"Reports on clinicaltrials.gov demonstrate that this trial is still enrolling participants, having been initially published on October 20th 2022 and last modified November 27th 2022."
What is the total enrollment of participants for this trial?
"Affirmative. Per the data on clinicaltrials.gov, this medical study is actively looking for 8 research volunteers from 1 centre and was initially posted on October 20th 2022 before its most recent update in late November of the same year."
Are there particular criteria for participating in this medical research?
"This trial is open to 8 participants aged between 18 and 55, who are deemed healthy subjects (hs). To guarantee the safety of all involved, additional criteria must be met. These include male gender, body mass index within a certain range, as well as specific values for blood tests results at screening and check-in stages."
Share this study with friends
Copy Link
Messenger